Pharming Group N.V. (PHAR)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 619.64M |
| Enterprise value | 584.88M |
| Trailing P/E | 26.71 |
| Forward P/E | 169.49 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.54 |
| Price/book (mrq) | 2.94 |
| Enterprise value/revenue | 2.26 |
| Enterprise value/EBITDA | 47.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.76 |
| 52-week change 3 | -29.41% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 16.71 |
| 52-week low 3 | 8.98 |
| 50-day moving average 3 | 10.38 |
| 200-day moving average 3 | 11.56 |
Share statistics
| Avg vol (3-month) 3 | 2.56k |
| Avg vol (10-day) 3 | 2.66k |
| Shares outstanding 5 | 67.34M |
| Implied shares outstanding 6 | 70.58M |
| Float 8 | 639.91M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.07% |
| Shares short (30 Apr 2024) 4 | 1.32k |
| Short ratio (30 Apr 2024) 4 | 1.49 |
| Short % of float (30 Apr 2024) 4 | N/A |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.01% |
| Shares short (prior month 28 Mar 2024) 4 | 1.48k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -4.18% |
| Operating margin (ttm) | -29.35% |
Management effectiveness
| Return on assets (ttm) | -3.53% |
| Return on equity (ttm) | -5.32% |
Income statement
| Revenue (ttm) | 258.36M |
| Revenue per share (ttm) | 3.91 |
| Quarterly revenue growth (yoy) | 30.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.32M |
| Net income avi to common (ttm) | -10.79M |
| Diluted EPS (ttm) | -0.16 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 201.97M |
| Total cash per share (mrq) | 0.31 |
| Total debt (mrq) | 167.21M |
| Total debt/equity (mrq) | 81.19% |
| Current ratio (mrq) | 1.43 |
| Book value per share (mrq) | 0.31 |
Cash flow statement
| Operating cash flow (ttm) | -2.16M |
| Levered free cash flow (ttm) | 28.45M |
© 2024 Yahoo. All rights reserved.